Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 50 Carcinoma, Non-Small-Cell Lung 36 Ovarian Neoplasms 35 Stomach Neoplasms 32 Esophageal Neoplasms 29 Uterine Cervical Neoplasms 21 Esophageal Squamous Cell Carcinoma 19 Fallopian Tube Neoplasms 16 Lung Neoplasms 13 Carcinoma, Ovarian Epithelial 13 Neoplasms 9 Head and Neck Neoplasms 9 Carcinoma, Squamous Cell 9 Triple Negative Breast Neoplasms 8 Recurrence 8 Neoplasm Metastasis 6 Endometrial Neoplasms 6 Advanced Gastric Cancer 6 Squamous Cell Carcinoma of Head and Neck 5 Pancreatic Neoplasms 5 Nasopharyngeal Neoplasms 5 Hypopharyngeal Neoplasms 4 Oropharyngeal Neoplasms 3 Nasopharyngeal Carcinoma 3 Mouth Neoplasms 3 Melanoma 3 Laryngeal Neoplasms 3 Carcinoma 3 Anus Neoplasms 3 Adenocarcinoma Of Esophagus 3

Interventions

130-nm albumin-bound paclitaxel 2 selinexor 1 pembrolizumab 1 isophosphamide mustard 1 epacadostat 1 Sunitinib 1 Ramucirumab 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Leucovorin 1 Histocompatibility Testing 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Epirubicin 1 Cyclophosphamide 1 Cisplatin 1 Chemoradiotherapy 1 Carboplatin 1 68Ga-pentixafor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Thymoma × Paclitaxel × Clear all

NCT03921671 2024-05-29

RELEVENT

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡